In this study, we directly measured serum 25OHD levels at surgery and examined the association with survival among patients with colorectal cancer. Methods We started a prospective cohort study to find prognostic factors in patients with colorectal cancer from 2003 to 2008 and stored serum samples and clinical data. As part of a post-hoc analysis, serum 25OHD levels were measured by radioimmunoassay. 